InfuSystem Holdings, Inc. (INFU) |
| 8.77 -0.42 (-4.57%) 02-27 16:00 |
| Open: | 9.04 |
| High: | 9.04 |
| Low: | 8.655 |
| Volume: | 121,588 |
| Market Cap: | 178(M) |
| PE Ratio: | 28.29 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 10.76 |
| Resistance 1: | 9.21 |
| Pivot price: | 7.96 |
| Support 1: | 8.04 |
| Support 2: | 7.32 |
| 52w High: | 11.04 |
| 52w Low: | 4.61 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Fri, 27 Feb 2026
InfuSystem posts 2025 record revenue $143.4M, adjusted EBITDA $31.5M; strong cash flow and $20M repurchase plan - TradingView
Fri, 27 Feb 2026
InfuSystem (NYSE: INFU) shows 2025 record revenue and margin gains - Stock Titan
Tue, 24 Feb 2026
InfuSystem Holdings, Inc. (NYSE:INFU) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Tue, 24 Feb 2026
InfuSystem Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Tue, 24 Feb 2026
Roth Capital Maintains Buy on INFU InfuSystem Holdings, Inc. Feb 24 2026 - Meyka
Tue, 24 Feb 2026
Earnings call transcript: InfuSystem Q4 2025 beats EPS expectations, stock surges - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |